Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

352
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
352

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relation-aware pre-trained network with hierarchical aggregation mechanism for cold-start drug recommendation.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Enhanced immobilization of cadmium, lead, and antimony with improved soil fertility using sulfate-reducing bacteria@nano zero-valent iron-modified biochar: coupled chemisorption and microbial mechanisms.

Frontiers in microbiology·2026
Same author

CNER-Omni: A unified dynamic modality learning framework for Chinese named entity recognition across text and speech.

Neural networks : the official journal of the International Neural Network Society·2025
Same author

Data Augmentation for Few-Shot Biomedical NER Using ChatGPT.

Artificial intelligence in medicine·2025
Same author

Traits improvement of wild rice O. rufipogon via multiplex genome editing.

Journal of integrative plant biology·2025
Same author

ADENER: A syntax-augmented grid-tagging model for Adverse Drug Event extraction in social media.

Journal of biomedical informatics·2025
Same journal

Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot.

iScience·2026
Same journal

ROS inhibits microtubule dynamics and cell growth heterogeneity during Arabidopsis sepal morphogenesis.

iScience·2026
Same journal

Type 1 diabetes alters early macrophage-<i>Mycobacterium tuberculosis</i> transcriptional coordination during infection.

iScience·2026
Same journal

Association of estimated pulse wave velocity with non-alcoholic fatty liver disease in multiple cohorts.

iScience·2026
Same journal

Effect of rolling surface texture on bearing friction pairs lubrication.

iScience·2026
Same journal

Whole blood exchange-lymphoplasmapheresis combined transfusion as an immunotherapy in systemic lupus erythematosus.

iScience·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Drug-target interaction prediction using knowledge graph embedding.

Nan Li1, Zhihao Yang1, Jian Wang1

  • 1College of Computer Science and Technology, Dalian University of Technology, Dalian, China.

Iscience
|July 2, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces TTModel, a novel knowledge graph embedding approach for predicting drug-target interactions (DTIs). TTModel enhances DTI prediction accuracy by integrating biomedical text and type information, outperforming existing methods.

Keywords:
BiochemistryComputational mathematicsComputer science

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 22, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Drug Discovery

Background:

  • Drug-target interaction (DTI) prediction is vital for drug development and repositioning.
  • Existing knowledge graph methods for DTI prediction face challenges with data sparseness and incomplete information.
  • Latent type information in knowledge graphs is often overlooked by current DTI prediction models.

Purpose of the Study:

  • To propose TTModel, a novel knowledge graph embedding model for improved DTI prediction.
  • To address limitations of existing methods by incorporating biomedical text and type information.
  • To enhance the accuracy and robustness of computational DTI prediction.

Main Methods:

  • Developed TTModel, a knowledge graph embedding model specifically for DTI prediction.
  • Utilized biomedical text semantics to enrich the knowledge graph representation.
  • Incorporated latent type information to improve the learning of node embeddings.
  • Evaluated the model on two public datasets for DTI prediction.

Main Results:

  • TTModel significantly outperforms state-of-the-art methods in DTI prediction.
  • The model demonstrates improved performance by effectively learning from text semantics and type information.
  • Experimental results validate the efficacy of TTModel on benchmark datasets.

Conclusions:

  • TTModel offers a superior approach for predicting drug-target interactions.
  • Integrating text and type information is crucial for enhancing knowledge graph-based DTI prediction.
  • The proposed method advances computational strategies in drug discovery and development.